Zuoying Armed Forces General Hospital

• print
• share to facebook
• share to line
• play audio

Meng-Lin Huang

Attending Physician

Education

• Graduated from the Department of Medicine of the National Defense Medical College
• Kaohsiung Medical University, Department of Pharmacy

Experience

• Specialist in surgery, Republic of China
• Digestive Surgery Specialist, Republic of China
• Colorectal Surgeon, Republic of China
• Surgical resident and chief physician at Zuoying General Hospital of the Nationalist Army
• Intern at the Department of Colorectal Surgery and General Surgery, Taipei Veterans General Hospital
• Chief Physician of Colorectal Surgery, Zuoying General Hospital of the Nationalist Army
• Taiwan Critical Care Medicine Specialist

Specialty

• Hemorrhoids, anal fistulas and abscesses, anal fissures, anal itching, surgery for abscesses and lumps in the buttocks, constipation, bloody stools, examination and removal of colorectal polyps , colorectal diverticula , surgical treatment and chemotherapy of colorectal malignant tumors, and painless colonoscopy.

Academic Works

• Successful management of perivascular epithelioid cell tumor of the rectum with recurrent liver metastases: A case report.
  • Lin KH, Chang NJ, Liou LR, Su MS, Tsao MJ, Huang ML.
  • Medicine (Baltimore). 2018 Aug;97(31):e11679. doi: 10.1097/MD.0000000000011679.
  • PMID: 30075560 Free PMC article.
• Spontaneous rupture of an extremely large gastrointestinal stromal tumor of the jejunum
  • Kung-Hung Lin, Meen-Lin Huange, Nai-Jen Chang, Li-ren Liou, Ming-Shan Su, Min-Jen Tsao
  • Formosan Journal of Surgery, 2016 Oct;49(5):196-200
• Clinical Implication of UGT1A1 Promoter Polymorphism for Irinotecan Dose Escalation in Metastatic Colorectal Cancer Patients Treated with Bevacizumab Combined with FOLFIRI in the First-line Setting.
  • Lu CY, Huang CW, Wu IC, Tsai HL, Ma CJ, Yeh YS, Chang SF, Huang ML, Wang JY.
  • Transl Oncol. 2015 Dec;8(6):474-9. doi: 10.1016/j.tranon.2015.11.002.
  • PMID: 26692528 Free PMC article.
• FOLFIRI combined with bevacizumab as first-line treatment for metastatic colorectal cancer patients with hyperbilirubinemia after UGT1A1 genotyping.
  • Yeh YS, Huang ML, Chang SF, Chen CF, Hu HM, Wang JY.
  • Med Princ Pract. 2014;23(5):478-81. doi: 10.1159/000358799. Epub 2014 Mar 8.
  • PMID: 24642571 Free PMC article.
•  Prognostic advantage of irinotecan dose escalation according to uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) genotyping in patients with metastatic colorectal cancer treated with bevacizumab combined with 5-fluorouracil/leucovorin with irinotecan in a first-line setting.
  • Lu CY, Huang CW, Hu HM, Tsai HL, Huang CM, Yu FJ, Huang MY, Chang SF, Huang ML, Wang JY.
  • Transl Res. 2014 Aug;164(2):169-76. doi: 10.1016/j.trsl.2013.12.009. Epub 2014 Jan 4.
  • PMID: 24462762
• Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome.
  • Huang MY, Wang JY, Huang ML, Chang HJ, Lin SR.
  • Int J Mol Sci. 2013 Feb 19;14(2):4121-34. doi: 10.3390/ijms14024121.
  • PMID: 23429196 Free PMC article.
• Laparoscopic cholecystectomy techniques with special care treatment in acute cholecystitis patients regardless of operation timing.
  • Meng FY, Tsao MZ, Huang ML, Huang HW.
  • Hepatogastroenterology. 2012 Jun;59(116):1006-9. doi: 10.5754/hge10188.
  • PMID: 22580649
• Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy.
  • Huang MY, Huang ML, Chen MJ, Lu CY, Chen CF, Tsai PC, Chuang SC, Hou MF, Lin SR, Wang JY.
  • Pharmacogenet Genomics. 2011 Jan;21(1):18-25. doi: 10.1097/FPC.0b013e3283415124.
  • PMID: 21057378 Clinical Trial.
• Gene expressions of HMGI-C and HMGI(Y) are associated with stage and metastasis in colorectal cancer.
  • Huang ML, Chen CC, Chang LC.
  • Int J Colorectal Dis. 2009 Nov;24(11):1281-6. doi: 10.1007/s00384-009-0770-7. Epub 2009 Jul 17.
  • PMID: 19609535